Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
692,415,408
-
Total 13F shares
-
531,561,894
-
Share change
-
-14,609,076
-
Total reported value
-
$5,603,149,203
-
Put/Call ratio
-
165%
-
Price per share
-
$10.54
-
Number of holders
-
258
-
Value change
-
-$165,817,358
-
Number of buys
-
158
-
Number of sells
-
97
Institutional Holders of Roivant Sciences Ltd. - COMMON STOCK (ROIV) as of Q1 2024
As of 31 Mar 2024,
Roivant Sciences Ltd. - COMMON STOCK (ROIV) was held by
258 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
531,561,894 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, VIKING GLOBAL INVESTORS LP, QVT Financial LP, BlackRock Inc., MORGAN STANLEY, FMR LLC, Rubric Capital Management LP, STATE STREET CORP, Patient Square Capital LP, and Woodline Partners LP.
This page lists
258
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.